Standout Papers

SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits 2024 202642
  1. SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits (2024)
    Alberto Preda, Fabrizio Montecucco et al. Cardiovascular Research

Immediate Impact

5 standout
Sub-graph 1 of 2

Citing Papers

Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications
2025 Standout
Inflammation in atherosclerosis: pathophysiology and mechanisms
2024 Standout
3 intermediate papers

Works of Alberto Preda being referenced

SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits
2024 Standout
Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting
2022
and 1 more

Author Peers

Author Last Decade Papers Cites
Alberto Preda 114 33 18 60 51 37 246
Giandomenico Bisaccia 122 45 35 54 51 30 271
G Kostelli 91 25 15 34 33 36 213
Marco Bernardi 118 45 31 28 26 46 232
Nadezhda G. Gumanova 104 44 15 49 41 42 243
Fatih Altunkaş 113 40 45 38 29 36 288
Sébastien Rubin 106 30 12 19 33 42 275
Michiaki Miyamoto 105 61 28 23 66 25 283
Sedat Üstündağ 50 48 13 29 36 36 249
Michal Pořízka 99 108 14 66 19 28 257
Fang Yong 87 42 12 93 26 19 239

All Works

Loading papers...

Rankless by CCL
2026